Regeneron (REGN) Stock Looks At A Discount To Earnings
Published . Updated .
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
This report does not map to a usual set of affected companies.
Directly affected
- REGN Regeneron Pharmaceuticals+32.6% 30d
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that Regeneron Pharmaceuticals belongs to, so it often moves with news about it.
- LLY Eli Lilly and+22.4% 30d
Eli Lilly and is a peer of Regeneron Pharmaceuticals in pharmaceutical preparations; rivals often move on the same news.
- JNJ Johnson & Johnson-1.7% 30d
Johnson & Johnson is a peer of Regeneron Pharmaceuticals in pharmaceutical preparations; rivals often move on the same news.
- ABBV AbbVie+7.8% 30d
AbbVie is a peer of Regeneron Pharmaceuticals in pharmaceutical preparations; rivals often move on the same news.
- MRK Merck+1.9% 18d
Merck is a peer of Regeneron Pharmaceuticals in pharmaceutical preparations; rivals often move on the same news.
- ABT Abbott Laboratories+6.9% 30d
Abbott Laboratories is a peer of Regeneron Pharmaceuticals in pharmaceutical preparations; rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| REGN | -12.91% | -12.29% | base | +3.67% | +5.06% | +1.93% | after close |
| XLV | -3.03% | -2.77% | base | -0.14% | -0.48% | +2.19% | after close |
| LLY | -9.71% | -8.92% | base | -0.37% | -0.54% | +0.21% | after close |
| JNJ | -2.53% | -0.72% | base | -0.98% | -2.59% | +0.22% | after close |
| ABBV | -2.71% | -2.90% | base | -2.03% | -3.03% | -1.00% | after close |
| MRK | -5.94% | -5.65% | base | -0.74% | -3.26% | -0.45% | after close |
| ABT | -1.26% | -3.36% | base | +3.81% | +2.97% | +8.70% | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Regeneron (REGN) Stock Looks At A Discount To Earnings Yahoo Finance
Source: Yahoo Finance
This story
| Company | When | Move | Status |
|---|---|---|---|
| ABBV | that day | -2.03% | final price |
| ABBV | the next day | -3.03% | final price |
| ABBV | two days later | -1.00% | still updating |
| ABBV | three days earlier | -2.90% | final price |
| ABBV | five days earlier | -2.71% | final price |
| ABT | that day | +3.81% | final price |
| ABT | the next day | +2.97% | final price |
| ABT | two days later | +8.70% | still updating |
| ABT | three days earlier | -3.36% | final price |
| ABT | five days earlier | -1.26% | final price |
| JNJ | that day | -0.98% | final price |
| JNJ | the next day | -2.59% | final price |
| JNJ | two days later | +0.22% | still updating |
| JNJ | three days earlier | -0.72% | final price |
| JNJ | five days earlier | -2.53% | final price |
| LLY | that day | -0.37% | final price |
| LLY | the next day | -0.54% | final price |
| LLY | two days later | +0.21% | still updating |
| LLY | three days earlier | -8.92% | final price |
| LLY | five days earlier | -9.71% | final price |
| MRK | that day | -0.74% | final price |
| MRK | the next day | -3.26% | final price |
| MRK | two days later | -0.45% | still updating |
| MRK | three days earlier | -5.65% | final price |
| MRK | five days earlier | -5.94% | final price |
| REGN | that day | +3.67% | final price |
| REGN | the next day | +5.06% | final price |
| REGN | two days later | +1.93% | still updating |
| REGN | three days earlier | -12.29% | final price |
| REGN | five days earlier | -12.91% | final price |
| XLV | that day | -0.14% | final price |
| XLV | the next day | -0.48% | final price |
| XLV | two days later | +2.19% | still updating |
| XLV | three days earlier | -2.77% | final price |
| XLV | five days earlier | -3.03% | final price |
Congressional trades in the stocks in this story
- Rep. Rohit Khanna sold Regeneron Pharmaceuticals (REGN) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 57 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 57 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Thomas H. Kean Jr sold Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 30 Sep 2026. That is 31 days before publication. Filed 30 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 36 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Lloyd Doggett bought Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 8 Sep 2026. That is 53 days before publication. Filed 5 Oct 2026. View the filing.
- Rep. Pete Sessions sold AbbVie (ABBV), worth $15,001 - $50,000 on 14 Sep 2026. That is 47 days before publication. Filed 18 Sep 2026. View the filing.
- Rep. Rohit Khanna sold AbbVie (ABBV) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 57 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar sold Merck (MRK), worth $1,001 - $15,000 on 24 Sep 2026. That is 37 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar bought Merck (MRK), worth $15,001 - $50,000 on 19 Aug 2026. That is 73 days before publication. Filed 9 Sep 2026. View the filing.
- Rep. Pete Sessions sold Abbott Laboratories (ABT) (held by a spouse), worth $50,001 - $100,000 on 2 Oct 2026. That is 29 days before publication. Filed 27 Oct 2026. View the filing.
- Rep. Gilbert Cisneros bought Abbott Laboratories (ABT), worth $1,001 - $15,000 on 18 Sep 2026. That is 43 days before publication. Filed 12 Oct 2026. View the filing.
- Rep. Thomas H. Kean Jr sold Abbott Laboratories (ABT), worth $1,001 - $15,000 on 17 Sep 2026. That is 44 days before publication. Filed 30 Oct 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
How solid “Regeneron (REGN) Stock Looks At A Discount To Earnings” looks
12 out of 100Price not final
“Regeneron (REGN) Stock Looks At A Discount To Earnings” scores 12 out of 100. The score uses 1 sources. The price is not final yet.